유방 병변 국소화법 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 지역별, 부문 예측(2025-2030년)

Breast Lesion Localization Methods Market Size, Share & Trends Analysis Report By Type (Wire Guided Localization, Radioisotope Localization, Magnetic Tracer), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,404,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,816,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,641,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

유방 병변 국소화법 시장의 성장 및 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 유방 병변 국소화법 시장 규모는 2030년까지 36억 2,000만 달러에 달할 것으로 예측되고, 2025-2030년의 CAGR은 7.9%를 나타낼 것으로 예측됩니다. 유방암 진단, 생검, 검사 및 관련 의료 절차에 대한 정부 및 비정부 환급 정책이 증가함에 따라 유방 병변 국소화 방법의 채택이 촉진될 것으로 예상됩니다. 또한 여성들의 유방암 유병률 증가로 인해 의료 인프라 및 시설 개선에 대한 수요가 증가함에 따라 시장 성장이 촉진될 것으로 예상됩니다.

여성의 유방암 발병률이 증가함에 따라 정밀한 조기 발견 방법에 대한 필요성이 높아지고 있습니다. 유방 병변 국소화 기술은 생검 또는 외과적 개입을 위해 의심스러운 병변을 정확하게 식별하고 표적을 지정하는 데 중추적인 역할을 합니다. 예를 들어, 미국 유방암 재단(National Breast Cancer Foundation, Inc.)의 보고서에 따르면 2024년 4월 미국에서는 여성 8명 중 1명이 평생 동안 유방암 진단을 받게 됩니다. 2024년에는 약 31만 720명의 여성과 2,800명의 남성이 침습성 유방암으로 진단될 것으로 예측됩니다. 유방암의 유병률이 증가함에 따라 맞춤형 치료 전략에 대한 관심이 높아지고 있습니다. 종양 전문의와 외과의는 첨단 병변 국소화 방법을 통해 최상의 환자 치료 결과를 목표로 세심하게 치료를 계획하고 시행할 수 있습니다. 이러한 요인으로 인해 유방 병변 국소화 방법에 대한 수요가 증가하고 있습니다.

디지털 유방조영술, 초음파, MRI와 같은 영상 기술의 발전으로 유방 병변의 탐지 및 특성 분석이 크게 향상되었습니다. 이에 따라 수술 절차를 정확하게 안내하기 위한 정밀한 국소화 기술에 대한 필요성이 증가하고 있습니다. 또한 3D 영상 장비와 내비게이션 시스템의 통합으로 외과의는 수술 중 실시간으로 유방 병변 위치를 시각화하여 수술 정밀도를 크게 향상시키고 환자 결과를 개선할 수 있습니다. 이러한 요인들이 예측 기간 동안 시장 성장을 촉진하고 있습니다.

유방 병변 국소화법 시장 보고서 하이라이트

• 제품 유형별로는 와이어 가이드 국소화 부문은 다양한 제품이 존재하고 최종 사용자 사이에서이 기술의 채택률이 높기 때문에 2024년에 가장 큰 시장 점유율을 차지했습니다.
• 방사성 동위 원소 국소화는 만져지지 않는 의심스러운 유방 병변의 수술 전 국소화를위한 효과적이고 안전하며 널리 사용되는 절차이기 때문에 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다.
• 북미는 이 지역의 주요 제조업체의 존재, 확립된 의료 인프라, 현지화 장치의 높은 채택으로 인해 2024년의 가장 높은 점유율로 시장을 독점하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 유방 병변 국소화법 시장 변수, 동향, 범위

• 시장 계통의 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 유방 병변 국소화법 시장 : 유형별 비즈니스 분석

• 유형별 시장 점유율(2024년, 2030년)
• 유형 부문 대시보드
• 시장 규모와 예측과 동향 분석, 유형별(2018-2030년)
• 와이어 가이드
• 자기 추적기
• 기타

제5장 유방 병변 국소화법 시장 : 지역별, 추정 및 동향 분석

• 지역별 시장 점유율 분석(2024년, 2030년)
• 지역별 시장 대시보드
• 시장 규모, 예측 동향 분석(2018-2030년)
• 북미
  • 국가별(2018-2030년)
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 국가별(2018-2030년)
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 덴마크
  • 스웨덴
• 아시아태평양
  • 국가별(2018-2030년)
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 국가별(2018-2030년)
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 국가별(2018-2030년)
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제6장 경쟁 구도

• 참가자 개요
• 기업의 시장 포지셔닝 분석
• 기업 분류
• 전략 매핑
• 기업 프로파일 및 상장 기업
  • BD
  • SOMATEX Medical Technologies GmbH(Hologic Inc.)
  • Argon Medical Devices
  • Merit Medical Systems
  • Cook
  • STERYLAB Srl
  • Theragenics Corporation
  • MDL SRL
  • MOLLI Surgical Inc.(스트라이커)

HBR

영문 목차

영문목차

Breast Lesion Localization Methods Market Growth & Trends:

The global breast lesion localization methods market size is anticipated to reach USD 3.62 billion by 2030 and is anticipated to grow at a CAGR of 7.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing government and non-government reimbursement policies for breast cancer diagnostics, biopsies, examinations, and related medical procedures are projected to drive adoption of breast lesion localization methods. Furthermore, the growing demand for improved healthcare infrastructure and facilities, driven by the rising prevalence of the disease among women, is anticipated to boost the market growth.

As the incidence of breast cancer among women rises, there is a heightened need for precise and early detection methods. Breast lesion localization techniques are pivotal in accurately identifying and targeting suspicious lesions for biopsy or surgical intervention. For instance, As per a report by National Breast Cancer Foundation, Inc., in April 2024, approximately 1 out of every 8 women in the U.S. will receive a breast cancer diagnosis during her lifetime. In 2024, it is projected that around 310,720 women and 2,800 men will be diagnosed with invasive breast cancer. With the increasing prevalence of breast cancer, there is a growing focus on tailored treatment strategies. Advanced lesion localization methods empower oncologists and surgeons to meticulously plan and deliver treatments, aiming for the best possible patient outcomes. These factors are driving the demand for breast lesions localizations methods.

Advancements in imaging technologies like digital mammography, ultrasound, and MRI have greatly improved the detection and characterization of breast lesions. As a result, there is an increased need for precise localization techniques to guide surgical procedures accurately. Furthermore, the integration of 3D imaging modalities and navigation systems allows surgeons to visualize breast lesion locations in real-time during procedures, significantly enhancing surgical precision and improving patient outcomes. These factors are propelling the market growth over the forecast period.

Breast Lesion Localization Methods Market Report Highlights:

• Based on type, the wire-guided localization segment held the largest market share in 2024 owing to the presence of a wide range of products and high adoption of this technique among end-users.
• Radioisotope localization is expected to witness significant growth over the forecast period as it is an effective, safe, and widely used procedure for preoperative localization of non-palpable, suspicious breast lesions.
• North America dominated the market with the highest revenue share in 2024 owing to the presence of key manufacturers in the region, established healthcare infrastructure, and high adoption of localization devices.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Breast Lesion Localization Methods Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Breast Lesion Localization Methods Market: Type Business Analysis

• 4.1. Type Market Share, 2024 & 2030
• 4.2. Type Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. Wire Guided Localization
  • 4.4.1. Wire Guided Localization Market, 2018 - 2030 (USD Million)
  • 4.4.2. Radioisotope Localization
    • 4.4.2.1. Radioisotope Localization Market, 2018 - 2030 (USD Million)
  • 4.4.3. Radio Guided Occult-Lesion Localization (ROLL)
    • 4.4.3.1. Radio Guided Occult-Lesion Localization (ROLL) Market, 2018 - 2030 (USD Million)
  • 4.4.4. Radioactive-Seed Localization (RSL)
    • 4.4.4.1. Radioactive-Seed Localization (RSL) Market, 2018 - 2030 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Others Market, 2018 - 2030 (USD Million)
• 4.5. Magnetic Tracer
  • 4.5.1. Magnetic Tracer Market, 2018 - 2030 (USD Million)
• 4.6. Others
  • 4.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Breast Lesion Localization Methods Market: Regional Estimates & Trend Analysis

• 5.1. Regional Market Share Analysis, 2024 & 2030
• 5.2. Regional Market Dashboard
• 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 5.4. North America
  • 5.4.1. North America Breast Lesion Localization Methods Market Estimates And Forecasts, By Country, 2018-2030 (USD Million)
  • 5.4.2. U.S.
    • 5.4.2.1. Key Country Dynamics
    • 5.4.2.2. Regulatory Framework
    • 5.4.2.3. Competitive Insights
    • 5.4.2.4. U.S. Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.4.3. Canada
    • 5.4.3.1. Key Country Dynamics
    • 5.4.3.2. Regulatory Framework
    • 5.4.3.3. Competitive Insights
    • 5.4.3.4. Canada Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.4.4. Mexico
    • 5.4.4.1. Key Country Dynamics
    • 5.4.4.2. Regulatory Framework
    • 5.4.4.3. Competitive Insights
    • 5.4.4.4. Mexico Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
• 5.5. Europe
  • 5.5.1. Europe Breast Lesion Localization Methods Market Estimates And Forecasts, By Country, 2018-2030 (USD Million)
  • 5.5.2. UK
    • 5.5.2.1. Key Country Dynamics
    • 5.5.2.2. Regulatory Framework
    • 5.5.2.3. Competitive Insights
    • 5.5.2.4. UK Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.5.3. Germany
    • 5.5.3.1. Key Country Dynamics
    • 5.5.3.2. Regulatory Framework
    • 5.5.3.3. Competitive Insights
    • 5.5.3.4. Germany Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.5.4. France
    • 5.5.4.1. Key Country Dynamics
    • 5.5.4.2. Regulatory Framework
    • 5.5.4.3. Competitive Insights
    • 5.5.4.4. France Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.5.5. Italy
    • 5.5.5.1. Key Country Dynamics
    • 5.5.5.2. Regulatory Framework
    • 5.5.5.3. Competitive Insights
    • 5.5.5.4. Italy Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.5.6. Spain
    • 5.5.6.1. Key Country Dynamics
    • 5.5.6.2. Regulatory Framework
    • 5.5.6.3. Competitive Insights
    • 5.5.6.4. Spain Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.5.7. Norway
    • 5.5.7.1. Key Country Dynamics
    • 5.5.7.2. Regulatory Framework
    • 5.5.7.3. Competitive Insights
    • 5.5.7.4. Norway Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.5.8. Denmark
    • 5.5.8.1. Key Country Dynamics
    • 5.5.8.2. Regulatory Framework
    • 5.5.8.3. Competitive Insights
    • 5.5.8.4. Denmark Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.5.9. Sweden
    • 5.5.9.1. Key Country Dynamics
    • 5.5.9.2. Regulatory Framework
    • 5.5.9.3. Competitive Insights
    • 5.5.9.4. Sweden Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
• 5.6. Asia Pacific
  • 5.6.1. Asia Pacific Breast Lesion Localization Methods Market Estimates And Forecasts, By Country, 2018-2030 (USD Million)
  • 5.6.2. Japan
    • 5.6.2.1. Key Country Dynamics
    • 5.6.2.2. Regulatory Framework
    • 5.6.2.3. Competitive Insights
    • 5.6.2.4. Japan Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.6.3. China
    • 5.6.3.1. Key Country Dynamics
    • 5.6.3.2. Regulatory Framework
    • 5.6.3.3. Competitive Insights
    • 5.6.3.4. China Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.6.4. India
    • 5.6.4.1. Key Country Dynamics
    • 5.6.4.2. Regulatory Framework
    • 5.6.4.3. Competitive Insights
    • 5.6.4.4. India Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.6.5. South Korea
    • 5.6.5.1. Key Country Dynamics
    • 5.6.5.2. Regulatory Framework
    • 5.6.5.3. Competitive Insights
    • 5.6.5.4. South Korea Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.6.6. Australia
    • 5.6.6.1. Key Country Dynamics
    • 5.6.6.2. Regulatory Framework
    • 5.6.6.3. Competitive Insights
    • 5.6.6.4. Australia Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.6.7. Thailand
    • 5.6.7.1. Key Country Dynamics
    • 5.6.7.2. Regulatory Framework
    • 5.6.7.3. Competitive Insights
    • 5.6.7.4. Thailand Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
• 5.7. Latin America
  • 5.7.1. Latin America Breast Lesion Localization Methods Market Estimates And Forecasts, By Country, 2018-2030 (USD Million)
  • 5.7.2. Brazil
    • 5.7.2.1. Key Country Dynamics
    • 5.7.2.2. Regulatory Framework
    • 5.7.2.3. Competitive Insights
    • 5.7.2.4. Brazil Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.7.3. Argentina
    • 5.7.3.1. Key Country Dynamics
    • 5.7.3.2. Regulatory Framework
    • 5.7.3.3. Competitive Insights
    • 5.7.3.4. Argentina Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
• 5.8. MEA
  • 5.8.1. MEA Breast Lesion Localization Methods Market Estimates And Forecasts, By Country, 2018-2030 (USD Million)
  • 5.8.2. South Africa
    • 5.8.2.1. Key Country Dynamics
    • 5.8.2.2. Regulatory Framework
    • 5.8.2.3. Competitive Insights
    • 5.8.2.4. South Africa Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.8.3. Saudi Arabia
    • 5.8.3.1. Key Country Dynamics
    • 5.8.3.2. Regulatory Framework
    • 5.8.3.3. Competitive Insights
    • 5.8.3.4. Saudi Arabia Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.8.4. UAE
    • 5.8.4.1. Key Country Dynamics
    • 5.8.4.2. Regulatory Framework
    • 5.8.4.3. Competitive Insights
    • 5.8.4.4. UAE Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 5.8.5. Kuwait
    • 5.8.5.1. Key Country Dynamics
    • 5.8.5.2. Regulatory Framework
    • 5.8.5.3. Competitive Insights
    • 5.8.5.4. Kuwait Breast Lesion Localization Methods Market Estimates And Forecasts, 2018-2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Participant Overview
• 6.2. Company Market Position Analysis
• 6.3. Company Categorization
• 6.4. Strategy Mapping
• 6.5. Company Profiles/Listing
  • 6.5.1. BD
    • 6.5.1.1. Overview
    • 6.5.1.2. Financial Performance
    • 6.5.1.3. Product Benchmarking
    • 6.5.1.4. Strategic Initiatives
  • 6.5.2. SOMATEX Medical Technologies GmbH (Hologic Inc.)
    • 6.5.2.1. Overview
    • 6.5.2.2. Financial Performance
    • 6.5.2.3. Product Benchmarking
    • 6.5.2.4. Strategic Initiatives
  • 6.5.3. Argon Medical Devices
    • 6.5.3.1. Overview
    • 6.5.3.2. Financial Performance
    • 6.5.3.3. Product Benchmarking
    • 6.5.3.4. Strategic Initiatives
  • 6.5.4. Merit Medical Systems
    • 6.5.4.1. Overview
    • 6.5.4.2. Financial Performance
    • 6.5.4.3. Product Benchmarking
    • 6.5.4.4. Strategic Initiatives
  • 6.5.5. Cook
    • 6.5.5.1. Overview
    • 6.5.5.2. Financial Performance
    • 6.5.5.3. Product Benchmarking
    • 6.5.5.4. Strategic Initiatives
  • 6.5.6. STERYLAB S.r.l.
    • 6.5.6.1. Overview
    • 6.5.6.2. Financial Performance
    • 6.5.6.3. Product Benchmarking
    • 6.5.6.4. Strategic Initiatives
  • 6.5.7. Theragenics Corporation
    • 6.5.7.1. Overview
    • 6.5.7.2. Financial Performance
    • 6.5.7.3. Product Benchmarking
    • 6.5.7.4. Strategic Initiatives
  • 6.5.8. MDL SRL
    • 6.5.8.1. Overview
    • 6.5.8.2. Financial Performance
    • 6.5.8.3. Product Benchmarking
    • 6.5.8.4. Strategic Initiatives
  • 6.5.9. MOLLI Surgical Inc. (Stryker)
    • 6.5.9.1. Overview
    • 6.5.9.2. Financial Performance
    • 6.5.9.3. Product Benchmarking
    • 6.5.9.4. Strategic Initiatives

관련자료